Advertisement
| case study for leukemia: Allogeneic Stem Cell Transplantation Hillard M. Lazarus, Mary J. Laughlin, 2010-03-02 Since the original publication of Allogeneic Stem Cell Transplantation: Clinical Research and Practice, Allogeneic hematopoietic stem cell transplantation (HSC) has undergone several fast-paced changes. In this second edition, the editors have focused on topics relevant to evolving knowledge in the field in order to better guide clinicians in decision-making and management of their patients, as well as help lead laboratory investigators in new directions emanating from clinical observations. Some of the most respected clinicians and scientists in this discipline have responded to the recent advances in the field by providing state-of-the-art discussions addressing these topics in the second edition. The text covers the scope of human genomic variation, the methods of HLA typing and interpretation of high-resolution HLA results. Comprehensive and up-to-date, Allogeneic Stem Cell Transplantation: Clinical Research and Practice, Second Edition offers concise advice on today's best clinical practice and will be of significant benefit to all clinicians and researchers in allogeneic HSC transplantation. |
| case study for leukemia: Case Studies in Pain Management Alan David Kaye, Rinoo V. Shah, 2014-10-16 Edited by internationally recognized pain experts, this book offers 73 clinically relevant cases, accompanied by discussion in a question-and-answer format. |
| case study for leukemia: Acute Leukemia Ashkan Emadi, MD, PhD, Judith E. Karp, MD, 2017-07-26 Acute Leukemia: An Illustrated Guide to Diagnosis and Treatment provides a comprehensive and concise visual reference on acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) seen in children and adults. This book addresses all aspects of AML and ALL including their risk factors, cytogenetics and mutational characteristics, diagnoses, clinical management and prognoses which are imperative and challenging for medical students, residents, hematology and medical oncology fellows, and even community oncologists and hematologists. It presents complex information relying predominantly on pictorial depictions rather than traditional text in a visually instructive format. It replaces the wordiness of a traditional textbook with original and adapted illustrations, instructive schemata and diagrams, photomicrographs, tables, detailed figure legends, and practical, ‘bite-sized’ text. The result is a visually engaging book that is easy to read, review, and remember. Crafted by world experts in the field, this digestible volume provides you with the must-know information that you can utilize when encountering AML and ALL patients who require immediate attention. Whether you are an early-career practitioner looking for quick guidance to managing a deadly disease or you are a seasoned clinician looking for a quick review of treatment protocols, this engaging format provides a unique and ‘go-to’ resource. Key Features: Contains over 40 tables and over 220 illustrations, histologic photomicrographs, flow diagrams, graphs, and schemata with detailed figure legends Presents complex scientific aspects such as cytogenetics and molecular mutations in a visually digestible and easy-to-understand format Provides helpful and evidence-based treatment recommendations when providing induction therapy, consolidation therapy, and bone marrow transplantation Includes unique chapters on managing psychosexual issues accompanying AML and ALL treatment as well as on the FDA drug development and clinical trial design process Includes digital access to the e-book as well as an online Image Bank |
| case study for leukemia: Childhood Acute Lymphoblastic Leukemia Ajay Vora, 2017-04-21 This book provides a comprehensive and up-to-date review of all aspects of childhood Acute Lymphoblastic Leukemia, from basic biology to supportive care. It offers new insights into the genetic pre-disposition to the condition and discusses how response to early therapy and its basic biology are utilized to develop new prognostic stratification systems and target therapy. Readers will learn about current treatment and outcomes, such as immunotherapy and targeted therapy approaches. Supportive care and management of the condition in resource poor countries are also discussed in detail. This is an indispensable guide for research and laboratory scientists, pediatric hematologists as well as specialist nurses involved in the care of childhood leukemia. |
| case study for leukemia: Williams Hematology, 10th Edition Kenneth Kaushansky, Marshall A. Lichtman, Josef T. Prchal, Marcel M. Levi, Linda J. Burns, 2021-01-14 The landmark text that has guided generations of hematologists and related practitioners―updated with the latest research findings and improved format and presentation Long revered for its comprehensiveness and extraordinary depth of detail, Williams Hematology provides essential coverage of the origins, pathophysiological mechanisms, and management of benign and malignant disorders of blood and marrow cells and coagulation proteins. The text contains a wealth of basic science and translational pathophysiology for optimal, lifelong learning. Experts in research and clinical hematology, the editors are known worldwide for their contributions to the field. This new edition contains everything that has made Williams Hematology the go-to resource for decades and has been updated with new chapters and critical new research into the molecular mechanisms responsible for hematological disorders and the impact on diagnosis and treatment. And the new format enables you to access each chapter via content modules covering key topics, with summaries, infographics, and cases―all linked to review questions for self-assessment. The full-color presentation integrates images of blood and tissue findings where they are cited in the text. NEW TO THIS EDITION: Updated and revised content reflecting the latest research and developments Convenient format that streamlines the learning process and improves retention Additional chapters added on: Immune Checkpoint Inhibitors Immune Cell Therapy: Chimeric Antigen Receptor T Cell Therapy Immune Cell Therapy Dendritic Cell and Natural Killer Cell Therapy The processes of cell death and survival Application of Big Data and Deep Learning in Hematology Williams Hematology Cases with multiple-choice questions including detailed explanations—perfect preparation for the boards Continuously updated online content with comprehensive drug therapy database and other resources |
| case study for leukemia: Hematologic Malignancies: Acute Leukemias S.H. Faderl, H.M. Kantarjian, 2007-11-21 Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. This hugely important new book describes the current knowledge of acute leukemia biology and discusses new classification systems that have arisen as a result of emerging insights into pathogenesis. Estey, Faderl and Kantarjian, who all work at the respected Anderson Cancer Center in Houston, Texas, USA, examine in detail advances in the treatment of particular types of acute leukemia. Their book also covers the management of acute leukemia in general as well as the development of new therapies. This book will be extremely useful to clinicians. |
| case study for leukemia: Hematology-Oncology Clinical Questions Julie Rowe, Anneliese Gonzalez, Syed Jafri, Putao Cen, Zeyad Kanaan, Robert Amato, Adan Rios, Hazem El Osta, Virginia Mohlere, 2018-11-02 A unique point-of-care guide to clinical hematology-oncology that answers the most frequently asked questionsHematology-Oncology Clinical Questions is the single-best resource for quickly converting the most current data and research into practical, diagnostic real-time solutions. This unique book answers more than 60 of the clinical hematology-oncology questions most commonly asked of the authors during consultation. The content flow simulates the consultation process: Question...Data...Synthesis...Solution. The initial chapters prepare you with essential background fundamentals of hematology-oncology. Subsequent chapters are divided into tumor type, beginning with solid tumor types, and then hematological malignancies. Each chapter includes:•Key Concepts•The Clinical Scenario•The Action Items•PearlsHematology-Oncology Clinical Questions will prove to be a powerful tool to help learners from all points of the clinical spectrum understand the basic concepts of caring for a cancer patient. |
| case study for leukemia: Hematology Case Review Donald C. Doll, Radwan F. Khozouz, Wes Matthew Triplett, 2013-10-24 Hematology Case Review is a comprehensive text that covers the expansive knowledge about the study of blood cells. After collecting blood smears and bone marrow aspirates for over 40 years, Dr. Doll has created the most up to date and comprehensive compilation of hematology case studies. These samples form the core of the case studies featured in this book, including benign disorders, such as hereditary spherocytosis, to neoplastic neoplasms like acute leukemia. Within the text, both rare and common conditions are discussed, with the presenting symptoms, blood counts, and pertinent images. The book is formatted in an interactive problem-based layout in order to enhance the question and answer features of the book. It is a widely applicable text that has been utilized for its practicality for over 15 years, and is becoming particularly important for general internists, family practice physicians, and hospitalists. Additionally, Hematology Case Review continues to be a vital tool and asset for medical students, medical residents, hematology-oncology fellows, and pathology residents. |
| case study for leukemia: Diagnostic Pathology Kathryn Foucar, 2012 Designed as an easy-to-use and comprehensive reference for the practicing pathologist, Diagnostic pathology: blood and bone marrow is the newest title in the Diagnostic pathology series by Amirsys. This extensively illustrated book showcases over 1,900 high-quality images, including gross pathology and a variety of pathology stains. Included are several images that display specialized immunophenotypic and molecular genetic features of bone marrow disorders. As readers have come to expect from Amirsys reference tools, the content is presented in concise, bulleted text that quickly gets to the most critical diagnostic data, including a variety of differential diagnoses. This book pinpoints important elements in the diagnosis of benign and neoplastic disorders and it clearly delineates numerous genetic disorders often found in blood and bone marrow. Diagnostic athology: blood and bone marrow is set to become a valuable reference resource for the busy pathologist--Provided by publisher. |
| case study for leukemia: The Immortal Life of Henrietta Lacks Rebecca Skloot, 2010-02-02 #1 NEW YORK TIMES BESTSELLER • “The story of modern medicine and bioethics—and, indeed, race relations—is refracted beautifully, and movingly.”—Entertainment Weekly NOW A MAJOR MOTION PICTURE FROM HBO® STARRING OPRAH WINFREY AND ROSE BYRNE • ONE OF THE “MOST INFLUENTIAL” (CNN), “DEFINING” (LITHUB), AND “BEST” (THE PHILADELPHIA INQUIRER) BOOKS OF THE DECADE • ONE OF ESSENCE’S 50 MOST IMPACTFUL BLACK BOOKS OF THE PAST 50 YEARS • WINNER OF THE CHICAGO TRIBUNE HEARTLAND PRIZE FOR NONFICTION NAMED ONE OF THE BEST BOOKS OF THE YEAR BY The New York Times Book Review • Entertainment Weekly • O: The Oprah Magazine • NPR • Financial Times • New York • Independent (U.K.) • Times (U.K.) • Publishers Weekly • Library Journal • Kirkus Reviews • Booklist • Globe and Mail Her name was Henrietta Lacks, but scientists know her as HeLa. She was a poor Southern tobacco farmer who worked the same land as her slave ancestors, yet her cells—taken without her knowledge—became one of the most important tools in medicine: The first “immortal” human cells grown in culture, which are still alive today, though she has been dead for more than sixty years. HeLa cells were vital for developing the polio vaccine; uncovered secrets of cancer, viruses, and the atom bomb’s effects; helped lead to important advances like in vitro fertilization, cloning, and gene mapping; and have been bought and sold by the billions. Yet Henrietta Lacks remains virtually unknown, buried in an unmarked grave. Henrietta’s family did not learn of her “immortality” until more than twenty years after her death, when scientists investigating HeLa began using her husband and children in research without informed consent. And though the cells had launched a multimillion-dollar industry that sells human biological materials, her family never saw any of the profits. As Rebecca Skloot so brilliantly shows, the story of the Lacks family—past and present—is inextricably connected to the dark history of experimentation on African Americans, the birth of bioethics, and the legal battles over whether we control the stuff we are made of. Over the decade it took to uncover this story, Rebecca became enmeshed in the lives of the Lacks family—especially Henrietta’s daughter Deborah. Deborah was consumed with questions: Had scientists cloned her mother? Had they killed her to harvest her cells? And if her mother was so important to medicine, why couldn’t her children afford health insurance? Intimate in feeling, astonishing in scope, and impossible to put down, The Immortal Life of Henrietta Lacks captures the beauty and drama of scientific discovery, as well as its human consequences. |
| case study for leukemia: Neoplastic Diseases of the Blood Peter H. Wiernik, 1985 |
| case study for leukemia: Oncology Board Review, Third Edition Francis P. Worden, MD, Rami N. Khoriaty, MD, Erin Cobain, MD, 2021-11-10 Now in its third edition, Oncology Board Review: Blueprint Study Guide and Q&A is designed to help you prepare for the American Board of Internal Medicine (ABIM) Medical Oncology Certification Exam. This comprehensive digital resource has been revised to include new treatment regimens, clinical guidelines, and other advancements impacting the field as well as updated board-style Q&A. Dedicated sections cover hematological malignancies and solid tumors with a templated chapter approach highlighting epidemiology, etiology and risk factors, diagnostic criteria, staging, signs and symptoms of the disease, prognostic factors, indications for treatment, and special considerations. Later sections address other topics found on the exam, including cancer genetics and tumor biology, supportive and palliative care, bone marrow transplantation, and biostatistics. With more than 240 practice questions and detailed rationales, Oncology Board Review gives you the tools to study your way and the confidence to pass the first time! Key Features: Aligns with the latest ABIM Medical Oncology Certification Exam blueprint Provides a comprehensive yet concise review of all hematologic malignancies and solid tumors Covers anticancer therapies, clinical research methodology, survivorship and palliative care, and more areas found on the exam Revised to include new treatment recommendations and FDA approvals Includes end-of-chapter assessment questions with detailed rationales - a total of more than 240 questions throughout |
| case study for leukemia: Clinical Case Studies for the Family Nurse Practitioner Leslie Neal-Boylan, 2011-11-28 Clinical Case Studies for the Family Nurse Practitioner is a key resource for advanced practice nurses and graduate students seeking to test their skills in assessing, diagnosing, and managing cases in family and primary care. Composed of more than 70 cases ranging from common to unique, the book compiles years of experience from experts in the field. It is organized chronologically, presenting cases from neonatal to geriatric care in a standard approach built on the SOAP format. This includes differential diagnosis and a series of critical thinking questions ideal for self-assessment or classroom use. |
| case study for leukemia: The Gerson Therapy Charlotte Gerson, Morton Walker, 2001 Offers a nutritional program that utilizes the healing powers of organic fruits and vegetables to reverse the effects of cancer and other illnesses. |
| case study for leukemia: Hematopathology E-Book Elaine Sarkin Jaffe, Daniel A. Arber, Elias Campo, Leticia Quintanilla-Fend, Attilio Orazi, 2016-06-27 The world's leading reference in hematopathology returns with this completely updated second edition. Authored by international experts in the field, it covers a broad range of hematologic disorders -- both benign and malignant -- with information on the pathogenesis, clinical and pathologic diagnosis, and treatment for each. Comprehensive in scope, it's a must-have resource for both residents and practicing pathologists alike. - Authored by the chief architects of the WHO classification in neoplasms of hematopoietic and lymphoid tissue. - Covers the newest diagnostic techniques, including molecular, immunohistochemical, and genetic studies. - Confirm or challenge your diagnostic interpretations by comparing specimens to over 1,000 high-quality color images. - Boasts detailed, practical advice from world leaders in hematopathology. - Places an emphasis on pathologic diagnoses, including molecular and genetic testing. - Updated with the most current WHO classifications of hematologic disease, including lymphoma and leukemia and peripheral T-cell lymphomas. - Covers hot topics in hematopathology, such as the latest genetic insights into lymphoma and leukemia; the new nomenclature for myelodysplastic syndromes; new developments on the subject of Grey zone lymphoma; and much more. - Expert Consult eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, images, and references from the book on a variety of devices. There's also a downloadable image bank, and Virtual Microscope Slides are featured in several chapters. |
| case study for leukemia: Williams Hematology, 9E Kenneth Kaushansky, Marshall A. Lichtman, Josef Prchal, Marcel M. Levi, Oliver W. Press, Linda J. Burns, Michael Caligiuri, 2015-12-23 Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. The world's most highly regarded reference text on the mechanisms and clinical management of blood diseases A Doody's Core Title for 2020! Edition after edition, Williams Hematology has guided generations of clinicians, biomedical researchers, and trainees in many disciplines through the origins, pathophysiological mechanisms, and management of benign and malignant disorders of blood cells and coagulation proteins. It is acknowledged worldwide as the leading hematology resource, with editors who are internationally regarded for their research and clinical achievements and authors who are luminaries in their fields. The Ninth Edition of Williams Hematology is extensively revised to reflect the latest advancements in basic science, translational pathophysiology, and clinical practice. In addition to completely new chapters, it features a full-color presentation that includes 700 photographs, 300 of which are new to this edition, and 475 illustrations. Recognizing that blood and marrow cell morphology is at the heart of diagnostic hematology, informative color images of the relevant disease topics are conveniently integrated into each chapter, allowing easy access to illustrations of cell morphology important to diagnosis. Comprehensive in its depth and breath, this go-to textbook begins with the evaluation of the patient and progresses to the molecular and cellular underpinnings of normal and pathological hematology. Subsequent sections present disorders of the erythrocyte, granulocytes and monocytes, lymphocytes and plasma cells, malignant myeloid and lymphoid diseases, hemostasis and thrombosis, and transfusion medicine. |
| case study for leukemia: The Comatose Patient Eelco F.M. Wijdicks, 2014-04-28 The Comatose Patient, Second Edition, is a critical historical overview of the concepts of consciousness and unconsciousness, covering all aspects of coma within 100 detailed case vignettes. This comprehensive text includes principles of neurologic examination of comatose patients as well as instruction of the FOUR Score coma scale, and also discusses landmark legal cases and ethical problems. As the Chair of Division of Critical Care Neurology at Mayo Clinic, Dr. Wijdicks uses his extensive knowledge to discuss a new practical multistep approach to the diagnosis of the comatose patient. Additionally, this edition includes extensive coverage of the interpretation of neuroimaging and its role in daily practice and decision making, as well as management in the emergency room and ICU. Dr. Wijdicks details long-term supportive care and an appropriate approach to communication with family members about end-of-life decision making. In addition, video clips on neurologic examination and neurologic manifestations seen in comatose patients can be found here: http://oxfordmedicine.com/comatosepatient2e. All video recordings from the first edition have been reformatted and remastered for optimal use, and several more video clips of patients have also been included. |
| case study for leukemia: Analysis of Cancer Risks in Populations Near Nuclear Facilities National Research Council, Division on Earth and Life Studies, Nuclear and Radiation Studies Board, Committee on the Analysis of Cancer Risks in Populations near Nuclear Facilitiesâ¬"Phase I, 2012-06-29 In the late 1980s, the National Cancer Institute initiated an investigation of cancer risks in populations near 52 commercial nuclear power plants and 10 Department of Energy nuclear facilities (including research and nuclear weapons production facilities and one reprocessing plant) in the United States. The results of the NCI investigation were used a primary resource for communicating with the public about the cancer risks near the nuclear facilities. However, this study is now over 20 years old. The U.S. Nuclear Regulatory Commission requested that the National Academy of Sciences provide an updated assessment of cancer risks in populations near USNRC-licensed nuclear facilities that utilize or process uranium for the production of electricity. Analysis of Cancer Risks in Populations near Nuclear Facilities: Phase 1 focuses on identifying scientifically sound approaches for carrying out an assessment of cancer risks associated with living near a nuclear facility, judgments about the strengths and weaknesses of various statistical power, ability to assess potential confounding factors, possible biases, and required effort. The results from this Phase 1 study will be used to inform the design of cancer risk assessment, which will be carried out in Phase 2. This report is beneficial for the general public, communities near nuclear facilities, stakeholders, healthcare providers, policy makers, state and local officials, community leaders, and the media. |
| case study for leukemia: Multiparameter Flow Cytometry in the Diagnosis of Hematologic Malignancies Anna Porwit, Marie Christine Béné, 2018-01-25 Master implementation of the techniques of flow cytometry in diagnosing complex haematological diseases and malignancies in patients, worldwide. Featuring World Health Organization recommendations on pre-analytical steps, instrument settings and panel construction, this invaluable manual offers invaluable support for those researching, practising and analyzing the cause of hematological malignancies. Authored by leading experts, this book puts flow-cytometry into everyday context. With a focus on multicolour panels, the manual provides readers an experienced understanding of effective, implementation techniques. Practitioners of all levels are offered a background in a variety of diseases presented alongside the most current methodology. Wide-ranging and comprehensive; detailed images of healthy blood, bone marrow and lymph-nodes are illustrated throughout, allowing for effective diagnosis. Through engaging with differential diagnoses, the manual offers an understanding of similar symptoms and mimicking malignancies, avoiding inaccurate results. Featuring in-depth descriptions of chronic diseases; users can reach accurate diagnosis, first time. |
| case study for leukemia: Case Studies in Modern Drug Discovery and Development Xianhai Huang, Robert G. Aslanian, 2012-05-29 Learn why some drug discovery and development efforts succeed . . . and others fail Written by international experts in drug discovery and development, this book sets forth carefully researched and analyzed case studies of both successful and failed drug discovery and development efforts, enabling medicinal chemists and pharmaceutical scientists to learn from actual examples. Each case study focuses on a particular drug and therapeutic target, guiding readers through the drug discovery and development process, including drug design rationale, structure-activity relationships, pharmacology, drug metabolism, biology, and clinical studies. Case Studies in Modern Drug Discovery and Development begins with an introductory chapter that puts into perspective the underlying issues facing the pharmaceutical industry and provides insight into future research opportunities. Next, there are fourteen detailed case studies, examining: All phases of drug discovery and development from initial idea to commercialization Some of today's most important and life-saving medications Drugs designed for different therapeutic areas such as cardiovascular disease, infection, inflammation, cancer, metabolic syndrome, and allergies Examples of prodrugs and inhaled drugs Reasons why certain drugs failed to advance to market despite major research investments Each chapter ends with a list of references leading to the primary literature. There are also plenty of tables and illustrations to help readers fully understand key concepts, processes, and technologies. Improving the success rate of the drug discovery and development process is paramount to the pharmaceutical industry. With this book as their guide, readers can learn from both successful and unsuccessful efforts in order to apply tested and proven science and technologies that increase the probability of success for new drug discovery and development projects. |
| case study for leukemia: Environmental Medicine Committee on Curriculum Development in Environmental Medicine, Institute of Medicine, 1995-05-12 People are increasingly concerned about potential environmental health hazards and often ask their physicians questions such as: Is the tap water safe to drink? Is it safe to live near power lines? Unfortunately, physicians often lack the information and training related to environmental health risks needed to answer such questions. This book discusses six competency based learning objectives for all medical school students, discusses the relevance of environmental health to specific courses and clerkships, and demonstrates how to integrate environmental health into the curriculum through published case studies, some of which are included in one of the book's three appendices. Also included is a guide on where to obtain additional information for treatment, referral, and follow-up for diseases with possible environmental and/or occupational origins. |
| case study for leukemia: Leukemia Joan Chamberlain, 1987 |
| case study for leukemia: Understanding and Managing Oncologic Emergencies Marcelle Kaplan, 2018 Thoroughly updated and expanded, the third edition of Understanding and Managing Oncologic Emergencies: A Resource for Nurses is a comprehensive yet practical guide to understanding and managing oncologic emergencies from the nursing perspective. |
| case study for leukemia: Tumors of the Bone Marrow Richard D. Brunning, Robert W. McKenna, 1994 |
| case study for leukemia: Cancer Incidence and Survival Among Children and Adolescents , 1999 |
| case study for leukemia: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues World Health Organization, 2001 This is the third volume in the new World Health Organization series on histological and genetic typing of tumours. Tumours of the haematopoietic and lymphoid tissues are covered. This was a collaborative project of the European Association for Haematolpathology and the Society for Haematopathology and others. The WHO classification is based on the principles defined in the Revised European-American Classification of Lymphoid Neoplasms (REAL) classification. Over 50 pathologists from around the world were involved in the project and proponents of all major lymphoma and leukaemia classifications have agreed to accept the WHO as the standard classification of haematological malignancies. So this classification represents the first true world wide concensus of haematologic malignancies. Colour photographs, magnetic resonance and ultrasound images and CT scans are included. |
| case study for leukemia: Pathophysiology of Blood Disorders Howard Franklin Bunn, Jon C. Aster, 2010-12-27 A concise full-color review of the mechanisms of blood diseases and disorders – based on a Harvard Medical School hematology course 4 STAR DOODY'S REVIEW! This is a superb book. Deceptively small, yet packs a wallop. The emphasis on principles instead of practice is welcome....The text is clear, concise, and surprisingly approachable for what could have been a very dense and dry discussion. I could not put this book down and read it entirely in one sitting. When was the last time anyone found a hematology textbook so riveting?--Doody's Review Service Hematological Pathophysiology is a well-illustrated, easy-to-absorb introduction to the physiological principles underlying the regulation and function of blood cells and hemostasis, as well as the pathophysiologic mechanisms responsible for the development of blood disorders. Featuring a strong emphasis on key principles, the book covers diagnosis and management primarily within a framework of pathogenesis. Authored by world-renowned clinician/educators at Harvard Medical School, Hematological Pathophysiology features content and organization based on a hematology course offered to second year students at that school. The book is logically divided into four sections: Anemias and Disorders of the Red Blood Cell, Disorders of Hemostasis and Thrombosis, Disorders of Leukocytes, and Transfusion Medicine; it opens with an important overview of blood and hematopoietic tissues. Features Succinct, to-the-point coverage that reflects current medical education More than 200 full-color photographs and renderings of disease mechanisms and blood diseases Each chapter includes learning objectives and self-assessment questions Numerous tables and diagrams encapsulate important information Incorporates the feedback of 180 Harvard medical students who reviewed the first draft -- so you know you’re studying the most relevant material possible |
| case study for leukemia: Williams Manual of Hematology, Eighth Edition Marshall A. Lichtman, Kenneth Kaushansky, Thomas J. Kipps, Josef T. Prchal, Marcel Levi, 2011-05-31 A full-color quick reference distilled from the world's leading hematology text |
| case study for leukemia: Clinical Case Studies in Physiotherapy Lauren Jean Guthrie, 2008-10-09 Starting a placement or rotation in an unfamiliar clinical area is exciting but can be daunting. CLINICAL CASE STUDIES IN PHYSIOTHERAPY provides invaluable advice and practical guidance on cases and problems encountered on a daily basis allowing you to work with ease and confidence. By adopting a problem solving approach to the cases through the use of questions and answers, the authors will help you to think constructively about each case within all the key specialities of physiotherapy.Starting a placement or rotation in an unfamiliar clinical area is exciting but can be daunting. CLINICAL CASE STUDIES IN PHYSIOTHERAPY provides invaluable advice and practical guidance on cases and problems encountered on a daily basis allowing you to work with ease and confidence. By adopting a problem solving approach to the cases through the use of questions and answers, the authors will help you to think constructively about each case within all the key specialities of physiotherapy. - Hints and tips to get you ready for clinical placement - How to secure your first physiotherapy post - Case studies in the following clinical areas: respiratory, orthopaedics, neurology, musculoskeletal out-patients, care of the elderly, mental health and womens health - Cases covering paediatrics also included |
| case study for leukemia: Williams Hematology Malignant Lymphoid Diseases Oliver W Press, Marshall A. Lichtman, John P. Leonard, 2018-01-12 Leukemias and lymphoid diseases as only Williams can cover themFeaturing content derived from Williams Hematology, Ninth Edition. this concise, full-color resource delivers comprehensive and current coverage of leukemias and lymphoid diseases. More than a sectional reprint, the book includes updated science and treatment recommendations not found in the 2015 release of Williams Hematology, Ninth Edition. Perfect for use at the point of care, Williams Malignant Lymphoid Diseases maintains a strong clinical focus with detailed discussion of clinical presentation, patient evaluation, and diagnosis, genetic basis, therapy, and management. •A handy quick summary appears at the beginning of each chapter•Includes the latest advances in common treatments of leukemias, such as targeted therapy, immunotherapy, bone marrow hematopoietic stem cell transplantation, and monoclonal antibodies |
| case study for leukemia: Specialist Training in Oncology E-Book Thankamma V Ajithkumar, Helen Hatcher, 2011-10-28 This textbook of oncology is aimed at specialist registrars in the early phase of their training. The basic concepts of cancer practice is touched upon in undergraduate and junior postgraduate years, but new trainees frequently seek additional resources to boost their knowledge in the field of Oncology. This title offers a concise account of the multidisciplinary management of common cancers and cancer-related problems appropriate to doctors at the start of their careers in this specialty. The content of the book is based on latest available evidence and reflects the training guidelines. Readable and concise style, aimed at the beginner in this specialty. Well illustrated in colour with graphics, clinical photographs and radiographs. Section on research methodology. Approachable design in the ‘Specialist Training in...’ series style. |
| case study for leukemia: Leukemias Stefan Faderl, Hagop Kantarjian, 2011-09-14 Edited by experts from one of the world’s largest leukemia centers, this book provides information on the biology of the variety of leukemic disorders, up-to-date diagnostic testing and many new developments in therapy. Chapters covering new treatments present an outlook for the future and explain the rationale for ongoing clinical trials. Topics include: Targeted therapy, e.g. tyrosine kinase inhibitors (Flt3, Aurora kinase inhibitors, kit inhibitors, BCR-ABL inhibitors) Ras inhibitors Epigenetic therapy (hypomethylaters and histone deacetylase inhibitors) Lenalidomide analogs New chemotherapy drugs, e.g. clofarabine, cloretazine, sapacitabine, forodesine Combinations of chemotherapy with kinase inhibitors (e.g. ALL induction protocols in combination with dasatinib or imatinib) New monoclonal antibodies (lumiliximab, humaxCD20, anti-CD40) Thrombopoietic agents Leukemias: Principles and Practice of Therapy Includes practical information to guide you in challenging situations, such as treatment of elderly patients, pregnancy, relapsed and refractory disease Incorporates chapters on supportive care and pharmacologic information about the most frequently used drugs in this area |
| case study for leukemia: Hematology Margarita Guenova, Gueorgui Balatzenko, 2018-06-27 Hematology has constantly been advancing in parallel with technological developments that have expanded our understanding of the phenotypic, genetic, and molecular complexity and extreme clinical and biological heterogeneity of blood diseases. This has in turn allowed for developing more effective and less toxic alternative therapeutic approaches directed against critical molecular pathways. The continuous and rather extensive influx of new information regarding the key features and underlying mechanisms as well as treatment options in hematology requires a frequent update of this topic. The primary objective of this book is to provide the specialists involved in the clinical management and experimental research in hematological diseases with comprehensive and concise information on some important theoretical and practical developments in the biology, clinical assessment, and treatment of patients, as well as on some molecular and pathogenetic mechanisms and the respective translation into novel therapies. |
| case study for leukemia: The History of Oncology D. J. Th. Wagener, 2009-07-13 ‘The story of oncology is not only fascinating but also contains many accounts of dead ends, chance discoveries, illusions, mistakes and disappointments alongside the few successes.’These words are taken from the introduction to this book. The author, professor emeritus of Medical Oncology, reviews all aspects of the problem of cancer from a historical perspective, from the oldest existing records to the latest scientific and medical advances. It will interest the many people engaged in the treatment of cancer to read how the current therapeutic methods came about, and the book may also provide inspiration for cancer researchers, and for all those directly or indirectly involved with cancer. The layman looking for background information on a particular treatment may find it useful too. The various chapters can be read independently. A glossary and a few explanatory diagrams augment the text.This book grew out of an invitation the author received to lecture on the history of oncology. During his background reading, he discovered that there was no single volume dealing with the entire history of the subject. Fortunately, however, a great deal of information could be found here and there in the literature. As he read, he was struck by the fascinating stories behind many discoveries, and felt impelled to put them together in a single comprehensive account. The results of his labors are presented in this remarkable volume.The author, Prof. D.J.Th. (Theo) Wagener, was head of the department of Medical Oncology at the Radboud University Nijmegen Medical Centre in the Netherlands from 1982 to 2001, chairman of the Educational Committee of the European Society of Medical Oncology (ESMO), a member of the Educational Committee of the American Society of Clinical Oncology (ASCO) and a member of various international scientific working groups, mainly of the European Organization for Research and Treatment of Cancer (EORTC). |
| case study for leukemia: Disease Management for Nurse Practitioners , 2002 This definitive reference has everything nurse practitioners need to manage diseases confidently. Organized by body system or disease category, the book covers more than 300 disorders, from coronary artery disease to latex allergy to thyroid cancer. For each condition, the text reviews causes, incidence, pathophysiology, clinical presentation, diagnostic tests, differential diagnosis, treatment guidelines (for drug therapy, surgery, diet, pain control, and behavior modification), patient teaching, and more. Healthy Living covers lifestyle behaviors. Clinical Caution highlights complications related to disease management. Age Alert showcases age-specific considerations for young and older patients. Hundreds of illustrations and charts throughout clarify key topics. |
| case study for leukemia: Delivering High-Quality Cancer Care Committee on Improving the Quality of Cancer Care: Addressing the Challenges of an Aging Population, Board on Health Care Services, Institute of Medicine, 2014-01-10 In the United States, approximately 14 million people have had cancer and more than 1.6 million new cases are diagnosed each year. However, more than a decade after the Institute of Medicine (IOM) first studied the quality of cancer care, the barriers to achieving excellent care for all cancer patients remain daunting. Care often is not patient-centered, many patients do not receive palliative care to manage their symptoms and side effects from treatment, and decisions about care often are not based on the latest scientific evidence. The cost of cancer care also is rising faster than many sectors of medicine--having increased to $125 billion in 2010 from $72 billion in 2004--and is projected to reach $173 billion by 2020. Rising costs are making cancer care less affordable for patients and their families and are creating disparities in patients' access to high-quality cancer care. There also are growing shortages of health professionals skilled in providing cancer care, and the number of adults age 65 and older--the group most susceptible to cancer--is expected to double by 2030, contributing to a 45 percent increase in the number of people developing cancer. The current care delivery system is poorly prepared to address the care needs of this population, which are complex due to altered physiology, functional and cognitive impairment, multiple coexisting diseases, increased side effects from treatment, and greater need for social support. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis presents a conceptual framework for improving the quality of cancer care. This study proposes improvements to six interconnected components of care: (1) engaged patients; (2) an adequately staffed, trained, and coordinated workforce; (3) evidence-based care; (4) learning health care information technology (IT); (5) translation of evidence into clinical practice, quality measurement and performance improvement; and (6) accessible and affordable care. This report recommends changes across the board in these areas to improve the quality of care. Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis provides information for cancer care teams, patients and their families, researchers, quality metrics developers, and payers, as well as HHS, other federal agencies, and industry to reevaluate their current roles and responsibilities in cancer care and work together to develop a higher quality care delivery system. By working toward this shared goal, the cancer care community can improve the quality of life and outcomes for people facing a cancer diagnosis. |
| case study for leukemia: Case Studies in Hematology and Coagulation Gene Ed Gulati, 2019 |
| case study for leukemia: Chronic Lymphoid Leukemias, Second Edition, Bruce D. Cheson, 2001-04-25 Written by over 50 internationally distinguished experts, 30 more than the first edition, and contains nine new chapters! Continuing in the esteemed tradition and heralded success of the first edition, Chronic Lymphoid Leukemias, Second Edition offers a full overview of chronic lymphocytic leukemia (CLL) from multiple perspectives-covering all major developments since the previous edition was published eight years ago. Chronicling the complete history and variations of CLL-type leukemia, the Second Edition reviews the origin, nature, and molecular differences between B-CLL and T-CLL/PLL leukemias analyzes core constituents of apoptosis and causes for dysregulation of programmed cell death (PCD) in B-CLL examines recent research on the role cytokines and regulatory molecules may play in cross-cell communication profiles commonly used vectors for somatic gene therapy, as well as the latest advances in genetic engineering and vector design and production utilizes up-to-the-minute techniques such as fluorescence in-situ hybridization (FISH) and comparative genomic hybridization (CGH) to detect genetic abnormalities and aberrations explores current measures of supportive care with splenectomy, cytokine proteins, and intravenous immunoglobulin applications identifies how to manage infectious and psychiatric complications in patients with CLL and much more! Provides contemporary results on the efficacy of nucleoside analog combinations such as ara-C with fludarabine and cladribine and on the emerging nucleosides nelarabine and clofarabine! Copiously supplemented with over 2500 literature references-1000 more than the first edition-Chronic Lymphoid Leukemias, Second Edition fulfills the reference needs of oncologists, hematologists, immunologists, pathologists, infectious disease specialists, internists, molecular biologists, and medical school students in these disciplines. |
| case study for leukemia: Pharmacotherapy Casebook Terry L. Schwinghammer, 2005 This casebook is designed to help students develop the skills required to identify and resolve drug therapy problems through the use of patient case studies. |
| case study for leukemia: Hematology Ronald Hoffman, 2005 |
CHRONIC MYELOID LEUKEMIA WITH INTENSE …
case report of Chronic Myeloid Leukaemia (CML) with extreme thrombocytosis. premenopausal woman with an age of 45-year-old was admitted with chief complaints of fatigue and …
Case 26-2021: A 49-Year-Old Man with Relapsed Acute …
Presentation of Case Dr. Richard A. Newcomb: A 49-year-old man was evaluated at this hospital because of relapsed acute myeloid leukemia (AML).
AML-214: Case Report: A Rare Case Presentation and …
Acute promyelocytic leukemia (APL) is an uncommon subtype of acute myeloid leukemia (AML) characterized by the translocation t (15;17) (q22; q21) with a favorable prognosis upon …
Case Report Acute Myeloid Leukemia M2 Transformed into …
This study reported an 82-year-old man with initial diagnosis of acute myeloid leukemia-M2. After three cycles of azacitidine combined with venetoclax chemotherapy, the bone marrow smear …
Case #22: Acute Monocytic Leukemia - Beckman
Table of Contents > Neoplastic Process of Myeloid Origin > Case #22: Acute Monocytic Leukemia EveryEventMaers Figure 2: This FS INT vs FS PEAK dot plot shows events in the Time gate.
Hairy Cell Leukemia: A Case Report - applications.emro.who.int
We repo11 a case of a middle aged male diagnosed as Hairy cell leukemia. Clinicohematologic features were fever, weight loss, splenomegaly, anemia and thrombocytopenia. Bone marrow …
A case of a leukocytosis diagnosed as chronic myeloid …
In one study, 13 of 2,182 patients who underwent health checkups were diagnosed with leukocytosis, and 2 of 6 were diagnosed with leukemia (0.1%)3). Here, we report a woman who …
HemaBlog Issue 3: A - dasit.it
Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children, accounting for 75-80% of childhood leukemias. It is characterized by two peaks in incidence: one occurring in …
Case Study Discussions on the Nurse’s Role in Caring for …
While two cases will be discussed in detail during the session, all four scenarios developed by our expert panel are included in this participant workbook as an ongoing reference, which will be …
Acute Promyelocytic Leukemia in 9 Years Old Male Child-A …
Acute promyelocytic leukemia (APL) is a rare form of acute myeloid leukemia (AML) comprising 5-8% of all cases of AML and 10% of de novo pediatric AML [1, 2].
Case Study: Diagnosis of Acute Myeloid Leukemia in a Middle …
Acute Myeloid Leukemia (AML) is complex and multifaceted, with particular challenges arising in the identification and differentiation of related conditions like
Designing Nursing Care Program Based on Johnson …
Aim: this paper has been developed aiming to investigate clinical function of Johnson behavioral model in the child suffering from Acute Lymphoblastic Leukemia (ALL) in an environment. …
Patient with Chronic Myeloid Leukemia: A Case Study
Chronic myeloid leukemia abbreviated as CML is a type of myeloproliferative disease characterized by the increased and unregulated growth of predominantly myeloid cells in the …
Acute Lymphocytic Leukemia - syracusemap.net
In an acute leukemia, the abnormal cells divide rapidly, quickly overtaking functional white and red blood cells. The most common form of cancer in children 0-14 years of age is acute …
Acute Promyelocytic Leukemia: A Case Study Correlating …
Acute Promyelocytic Leukemia (APL) is a subclass of acute myeloid leukemia characterized by immature leukemic promyelocytes in the bone marrow and peripheral blood. Present in around …
A Case Study of Child with Acute Lymphoblastic Leukemia …
This article describes the case of a child, from the first symptoms, through the diagnosis and treatment due to acute lymphoblastic leukemia, who de- veloped significant hemostatic …
HemaBlog Issue 4: A - dasit.it
Case study of Chronic Lymphocytic Leukemia (CLL) Clinical information. The patient, a 74-year-old male with chronic lymphocytic leukemia, revisited the hematology clinic outpatient …
Advances in the Treatment of Relapsed/Refractory Acute …
Abstract: Acute lymphoblastic leukemia (ALL) is a heterogeneous hematologic malignancy characterized by proliferation of immature lymphoid cells throughout the bone marrow and …
Acute Myeloid Leukemia Case after Gene Therapy for Sickle …
Dec 12, 2021 · Acute myeloid leukemia developed in a woman approximately 5.5 years after she had received LentiGlobin for sickle cell disease as part of the initial cohort (Group A) of the …
EDuCATIONAL IMPLICATIONS OF THE SuBTLE LATE EFFECTS …
This paper presents a four-year longitudinal case study of a nine-year-old student when he was diagnosed with leukemia. Cognitive, neuropsychological, and affective functioning both pre and …
CHRONIC MYELOID LEUKEMIA WITH INTENSE …
case report of Chronic Myeloid Leukaemia (CML) with extreme thrombocytosis. premenopausal woman with an age of 45-year-old was admitted with chief complaints of fatigue and …
Case 26-2021: A 49-Year-Old Man with Relapsed Acute …
Presentation of Case Dr. Richard A. Newcomb: A 49-year-old man was evaluated at this hospital because of relapsed acute myeloid leukemia (AML).
AML-214: Case Report: A Rare Case Presentation and …
Acute promyelocytic leukemia (APL) is an uncommon subtype of acute myeloid leukemia (AML) characterized by the translocation t (15;17) (q22; q21) with a favorable prognosis upon …
Case Report Acute Myeloid Leukemia M2 Transformed into …
This study reported an 82-year-old man with initial diagnosis of acute myeloid leukemia-M2. After three cycles of azacitidine combined with venetoclax chemotherapy, the bone marrow smear …
Case #22: Acute Monocytic Leukemia - Beckman
Table of Contents > Neoplastic Process of Myeloid Origin > Case #22: Acute Monocytic Leukemia EveryEventMaers Figure 2: This FS INT vs FS PEAK dot plot shows events in the Time gate.
Hairy Cell Leukemia: A Case Report - applications.emro.who.int
We repo11 a case of a middle aged male diagnosed as Hairy cell leukemia. Clinicohematologic features were fever, weight loss, splenomegaly, anemia and thrombocytopenia. Bone marrow …
A case of a leukocytosis diagnosed as chronic myeloid …
In one study, 13 of 2,182 patients who underwent health checkups were diagnosed with leukocytosis, and 2 of 6 were diagnosed with leukemia (0.1%)3). Here, we report a woman …
HemaBlog Issue 3: A - dasit.it
Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children, accounting for 75-80% of childhood leukemias. It is characterized by two peaks in incidence: one occurring in …
Case Study Discussions on the Nurse’s Role in Caring for …
While two cases will be discussed in detail during the session, all four scenarios developed by our expert panel are included in this participant workbook as an ongoing reference, which will be …
Acute Promyelocytic Leukemia in 9 Years Old Male Child-A …
Acute promyelocytic leukemia (APL) is a rare form of acute myeloid leukemia (AML) comprising 5-8% of all cases of AML and 10% of de novo pediatric AML [1, 2].
Case Study: Diagnosis of Acute Myeloid Leukemia in a …
Acute Myeloid Leukemia (AML) is complex and multifaceted, with particular challenges arising in the identification and differentiation of related conditions like
Designing Nursing Care Program Based on Johnson …
Aim: this paper has been developed aiming to investigate clinical function of Johnson behavioral model in the child suffering from Acute Lymphoblastic Leukemia (ALL) in an environment. …
Patient with Chronic Myeloid Leukemia: A Case Study
Chronic myeloid leukemia abbreviated as CML is a type of myeloproliferative disease characterized by the increased and unregulated growth of predominantly myeloid cells in the …
Acute Lymphocytic Leukemia - syracusemap.net
In an acute leukemia, the abnormal cells divide rapidly, quickly overtaking functional white and red blood cells. The most common form of cancer in children 0-14 years of age is acute …
Acute Promyelocytic Leukemia: A Case Study Correlating …
Acute Promyelocytic Leukemia (APL) is a subclass of acute myeloid leukemia characterized by immature leukemic promyelocytes in the bone marrow and peripheral blood. Present in around …
A Case Study of Child with Acute Lymphoblastic Leukemia …
This article describes the case of a child, from the first symptoms, through the diagnosis and treatment due to acute lymphoblastic leukemia, who de- veloped significant hemostatic …
HemaBlog Issue 4: A - dasit.it
Case study of Chronic Lymphocytic Leukemia (CLL) Clinical information. The patient, a 74-year-old male with chronic lymphocytic leukemia, revisited the hematology clinic outpatient …
Advances in the Treatment of Relapsed/Refractory Acute …
Abstract: Acute lymphoblastic leukemia (ALL) is a heterogeneous hematologic malignancy characterized by proliferation of immature lymphoid cells throughout the bone marrow and …
Acute Myeloid Leukemia Case after Gene Therapy for …
Dec 12, 2021 · Acute myeloid leukemia developed in a woman approximately 5.5 years after she had received LentiGlobin for sickle cell disease as part of the initial cohort (Group A) of the …
EDuCATIONAL IMPLICATIONS OF THE SuBTLE LATE …
This paper presents a four-year longitudinal case study of a nine-year-old student when he was diagnosed with leukemia. Cognitive, neuropsychological, and affective functioning both pre …
